Crystalline form of ferric maltol

A technology of iron maltol and maltol, which is applied in the field of new polymorphs of compounds, and can solve the problems of not identifying or studying polymorphs and the like

Active Publication Date: 2020-05-22
SHIELD TX (UK) LTD
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Ferric maltol has been known for about 100 years, but no polymorphs were identified or studied prior to the present invention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Crystalline form of ferric maltol
  • Crystalline form of ferric maltol
  • Crystalline form of ferric maltol

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0190] Example 1: Type I

[0191] Combine 9.04 kg of ferric citrate with 29 liters of purified water. Separately 12.2 kg of maltol was combined with 15.2 liters of sodium hydroxide solution (20% w / w). Add ferric citrate and sodium hydroxide to the container, add 4 liters of water, and stir at 20°C to 25°C. Then add the seeds. The seed crystals were 65 g of ferric maltol polymorph in 12 liters of water. The seed crystals were prepared by the same method as described in Example 1, but no seed crystals were used. Add seeds to the vessel to aid consistent crystallization / precipitation. The mixture was kept in a suspension in a vessel to allow crystal growth, then filtered and washed three times with 13 liters of water each time. The resulting solid was dried below 80°C and yielded 13.25 kg dry ferric maltol.

[0192] The ferric maltol in Example 1 was produced in different batches on a scale of 12 kg to 15 kg. Analysis of the ferric maltol produced showed that the % w / w o...

Embodiment 1a

[0194] Production of ferric maltol via recrystallization with and without type II inoculation

[0195] Ferric citrate (15g, 6.12×10 -2 mol) was dissolved in water (60ml) and heated at reflux with stirring to aid dissolution. The solution was then cooled to room temperature. In a separate reaction vessel, maltol (19.17 g, 0.152 mol) was placed in 6M sodium hydroxide (27 ml) with stirring at room temperature until the solids were completely dissolved. The solution was then fine filtered.

[0196] The ferric citrate solution was added to the sodium maltate solution with stirring at room temperature. Precipitate formation was observed after about 15 minutes. The mixture was sampled after stirring for 2 hours and 4 hours. XRPD analysis showed a solid comparable to Form I. The slurry was then stirred overnight. The mixture was filtered under suction and most of the solids were dried in a vacuum oven (45°C). A small portion of solid (3 g) was removed and dried at 80°C without...

Embodiment 2

[0200] Example 2: Type II

[0201] Ferric maltol in Example 2 was produced using the general method as described in Example 1, but in larger batches of 24 kg to 33 kg.

[0202] Analysis of the ferric maltol produced showed that the % w / w of iron present was about 12.7% w / w and the % w / w of maltol present was about 88% w / w to 88.6% w / w.

[0203] The XRPD pattern of the type II polymorph obtained via Example 1a is shown in Figure 5 middle.

[0204] Analysis of the ferric maltol produced showed that in different batches the % w / w of iron present was about 12.7% w / w to 12.9% w / w and the % w / w of maltol present was about 86.7% w / w to 87.1% w / w. However, the ferric maltol seeds used in Example 2 were seeds of the Form I and Form II polymorphs.

[0205] Precipitated ferric maltol was also kept in the wet slurry for a longer time than Example 1.

[0206] The XRPD pattern of the type II polymorph obtained via Example 1a is shown in Figure 5 middle.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
solubility (mass)aaaaaaaaaa
solubility (mass)aaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

The present invention provides polymorphs of ferric maltol. These forms can be useful in the treatment of iron deficiency with or without anemia, such as iron deficiency anemia.

Description

technical field [0001] The present invention relates to new polymorphic forms of compounds, pharmaceutical compositions containing them, and methods for obtaining them. Background technique [0002] Sufficient iron supply to the body is an essential requirement for tissue growth and maintenance of good health in both humans and animals. Furthermore, in certain pathological states where there is occult blood loss or where there is an uneven distribution of iron in the body, there may be a state of low iron stores in the body, leading to iron deficiency and concomitant chronic anemia. This is seen in inflammatory diseases of the gastrointestinal tract, such as gastric and peptic ulcers, reflux esophagitis, ulcerative colitis, and Crohn's disease. [0003] Anemia can also occur after surgery that results in severe blood loss and can be associated with gastrointestinal infections, such as those caused by Helicobacter pylori. [0004] Ferric maltol contains a complex of ferric ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D309/40A61K31/351A61P7/06
CPCC07D309/40C07B2200/13A61P3/02A61P3/12A61P7/06A61K31/351C07F15/025
Inventor D·P·蔡尔兹
Owner SHIELD TX (UK) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products